Apotex Australia, an affiliate of Apotex Inc., headquartered in Toronto, has announced a proposed merger of its Australian and New Zealand generic pharmaceutical and over-the-counter (OTC) operations with Arrow Pharmaceuticals. The proposed merger is still subject to several conditions, including approval from the Australian Competition and Consumer Commission and due diligence. The combined operation, if approved, will become one of Australia's leading pharmaceutical companies. Arrow Pharmaceuticals is the Australian operating business of Strides Ltd, held through Singapore, and markets a broad range of more than 180 generic pharmaceutical products, and a pharmacy-only OTC products range to pharmacies Australia-wide. Apotex Inc. is one of the world's leading generic pharmaceutical companies. The company has over 10,000 employees, exports to more than 115 countries and territories, and operates in more than 45 countries, occupying a significant presence in the US, Mexico and India.